Hospira Gemcitabine for IV Infusion 200 mg

Nchi: Australia

Lugha: Kiingereza

Chanzo: Department of Health (Therapeutic Goods Administration)

Viambatanisho vya kazi:

gemcitabine hydrochloride, Quantity: 45.54 mg/mL

Inapatikana kutoka:

Hospira Australia Pty Ltd

INN (Jina la Kimataifa):

Gemcitabine hydrochloride

Dawa fomu:

Injection, intravenous infusion

Tungo:

Excipient Ingredients: mannitol; sodium acetate trihydrate

Njia ya uendeshaji:

Intravenous Infusion

Vitengo katika mfuko:

1 X 10 mL vial

Darasa:

Medicine Listed (Export Only)

Dawa ya aina:

(S1) This Schedule is intentionally blank

Matibabu dalili:

Non-small cell lung cancer, pancreatic cancer, biliary tract cancer, uroepithelial cancer, inoperable or recurrent breast cancer, ovarian cancer progressing after chemotherapy.

Bidhaa muhtasari:

Visual Identification: A white to off white lyophilized powder in a clear glass vial; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 36 Months; Container Temperature: Store between 15-25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Idhini hali ya:

Listed (Export Only)

Idhini ya tarehe:

2013-01-07